(19)

(11)

EP 4 271 377 A1

(12)

(43) Date of publication: 08.11.2023 Bulletin 2023/45 (21) Application number: 21916609.7 (22) Date of filing: 29.12.2021

(51) International Patent Classification (IPC):  A61K 31/42(2006.01) A61K 31/4245(2006.01) C07D 261/02(2006.01) A61K 31/422(2006.01) A61K 31/41(2006.01) A61K 31/445(2006.01) (52) Cooperative Patent Classification (CPC): C07D 413/14; C07D 451/06; C07D 417/14; A61P 43/00 (86) International application number: PCT/US2021/073153 (87) International publication number: WO 2022/147448 (07.07.2022 Gazette 2022/27)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 30.12.2020 US 202063132363 P (71) Applicant: Terns Pharmaceuticals, Inc. Foster City, California 94404 (US)	(72) Inventors: XU, Yingzi Foster City, CA 94404 (US) KLUCHER, Kevin Foster City, CA 94404 (US) ROMERO, F., Anthony Foster City, CA 94404 (US) (74) Representative: Cooley (UK) LLP  22 Bishopsgate London EC2N 4BQ London EC2N 4BQ (GB)